Cancer BiologybioRxivPreprint
FADS1/2-mediated lipid metabolic reprogramming drives ferroptosis sensitivity in triple-negative breast cancer
N. Lorito, A. Subbiani, A. Smiriglia…·A. Morandi
The paper identifies FADS1/2-mediated lipid metabolic reprogramming as a driver of ferroptosis sensitivity in triple-negative breast cancer, showing that high FADS1/2 expression correlates with poor prognosis and susceptibility to ferroptosis-inducing agents.
DOI 10.1101/2023.06.30.547227